Skip to content

Author

R. Baharlou

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

MF-59 Adjuvant Alum in an Inactivated SARS-CoV-2 Vaccine Model: Focusing on Heterologous Antigen-Binding Response

Background: Clarifying the role of an adjuvant in vaccine formulation on the induction of a higher cross-reactivity response is very important in the vaccine formulation. In this study, the inactivated Wuhan-Hu-1 strain of SARS-CoV-2 virus was formulated in MF-59 and Alum adjuvants and the immunogenicity of these vacci...

Tadeh Sepanian, A. Khorasani, Bizhan Sadighi Moghaddam et al. · 0 citations
Review Open access Sep 2026

Immunopeptidomics-guided cancer vaccine design: Advances, challenges, and emerging opportunities.

How immunopeptidomics is contributing to next-generation cancer vaccine development is discussed, the major translational challenges are summarized, and emerging concepts that may improve the clinical applicability of immunopeptidomics-guided immunotherapy are highlighted.

Mohammad Mahdi Behzadifar, Mahshid Shadkam, Saba Kazemi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.